icon- folder.gif   Conference Reports for NATAP  
 
  Back grey_arrow_rt.gif
 
 
 
 
 
IAC 2020: Aging, Comorbidities, weight changes, HCV-MSM, NAFLD, Challenges-Unmet Needs of elderly PLWH
 
 
  IAC 2020 Virtual: Pooled Analysis of 4 International Trials of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Adults Aged ≥ 65 Years Demonstrating Safety and Efficacy: Week 48 Results - (07/09/20)
 
IAC 2020 Virtual: Early weight changes associated with bictegravir-based regimens compared to other integrase inhibitors following ART-initiation in ART-naïve people living with HIV - (08/10/20)
 
IAC 2020 Virtual: Is NAFLD the same disease in HIV infected patients? - (08/10/20)
 
IAC 2020 Virtual: Patterns of Antiretroviral Use and Immunologic Correlates at Study Entry in the REPRIEVE Trial - (08/04/20)
 
IAC 2020 Virtual: Cardiovascular and metabolic comorbidities in HIV-infected patients in Colombia: A multicenter study - (07/27/20)
 
IAC 2020 Virtual: Persons Living With HIV (PLWH) in Japan on 2-Drug Regimen Reveal More Complex Patient Profiles Than That of 3-Drug Regimen Cohort - (07/27/20)
 
IAC 2020 Virtual: Changes in Body Mass Index Over Time in Persons With and Without HIV - Kaiser - (07/27/20)
 
The ADVANCE trial: Phase 3, randomised comparison of TAF/FTC+DTG, TDF/FTC+DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infection. - (07/15/20)
 
The predicted risk of adverse pregnancy outcomes from treatment-induced obesity in the ADVANCE trial. - Dolutegravir With TAF or TDF Could Increase Adverse Pregnancy Outcomes - (07/15/20)
 
Weight change among treatment naive women initiating dolutegravir in the ARIA study - (07/11/20)
 
Weight gain and hyperglycemia during the dolutegravir transition in Africa - (07/10/20)
 
WEIGHT CHANGES AFTER SWITCH TO DORAVIRINE/LAMIVUDINE/TDF IN THE DRIVE-SHIFT TRIAL - (07/07/20)
 
Weight gain before and after switch from TDF to TAF - (07/07/20)
 
People With HIV Gaining Weight 3 Times Faster Than HIV-Negatives in US - Mark Mascolini (07/06/20)
 
Early Weight Gain Up to 4.5 Kg/Year With Switch From TDF to TAF: Data Suggest Independent Effect of TAF on Weight - (07/06/20)
 
Only Small Weight Gains After Trial Switch to Doravirine/3TC/TDF - (07/06/20)
 
ISLATRAVIR (ISL, MK-8591) SAFETY ANALYSIS THROUGH WEEK 48 FROM A PHASE 2 TRIAL IN TREATMENT NAÏVE ADULTS WITH HIV-1 INFECTION - (07/08/20)
 
Islatravir Safety Through 48 Weeks With Doravirine in Phase 2 Trial - (07/09/20)
 
Doravirine, Islatravir at AIDS2020 IAC - (07/09/20)
 
Weight/Body Mass Index Gains Following Initiation of Integrase Strand Transfer Inhibitor Versus Protease Inhibitor Among People Living With Human Immunodeficiency Virus in the United States - (07/09/20)
 
 Aging, Comorbidities, Health Decline in AGING HIV+, Doctor-PLWH Communications Barriers, HCV in MSM
 
 Projecting the burden of multimorbidity among men who have sex with men living with HIV in the US - (07/09/20)
 
Dolutegravir With TAF or TDF Could Increase Adverse Pregnancy Outcomes - (07/15/20)
 
Challenges faced by a population aging with HIV: Baseline data from the CORE healthy aging initiative (CHAI) - (07/07/20)
 
UNDERSTANDING THE CHANGING TREATMENT CONCERNS OF OLDER PEOPLE LIVING WITH HIV (PLHIV) AND DIFFICULTIES WITH PATIENT-PROVIDER COMMUNICATION - (07/09/20)
 
Almost Half of Older HIV+ Adults Report Poor Overall Health in 25-Country Survey - (07/15/20)
 
Global HCV Burden Greater in MSM, Especially HIV+ Men: Meta-Analysis - (07/13/20)
 
HCV Reinfection Rate 40% in Netherlands HIV+ MSM 5 Years After Clearance - (07/13/20)
 
Global Positive Perspectives Study, Wave 2: Understanding the Unmet Needs of People Living with HIV - (07/15/20)
 
Clinical and sociodemographic characteristics associated with poor self-rated health across multiple domains among older adults living with HIV - (07/10/20)
 
Cardiovascular Risk Estimation is Sub-optimal Across Two HIV Cohort - (07/15/20)
 
Neuropathy and Neuropathic Pain Still on Rise in HIV+, But No Clear Links to ART - (07/10/20)
 
Projecting the burden of multimorbidity among men who have sex with men living with HIV in the US - (07/09/20)
 
PUTTING THE HEART BACK INTO HAART: GREATER HCP-PATIENT ENGAGEMENT IS ASSOCIATED WITH BETTER HEALTH OUTCOMES AMONG PERSONS LIVING WITH HIV (PLHIV) ON TREATMENT - (07/17/20)
 
Characteristics of Patients Living with HIV (PLWH) and HIV Treatment Outcomes in Community Practices in Southern vs Non-Southern US Regions - (07/16/20)
 
FACTORS ASSOCIATED WITH RESILIENCE AMONG OLDER PEOPLE LIVING WITH HIV - (07/16/20)
 
MODEL-BASED APPROACH OF DOSE SELECTION AND OPTIMAL PK SAMPLING OF FOSTEMSAVIR FOR PEDIATRIC PATIENTS WITH MULTIDRUG RESISTANT HIV-1 INFECTION - (07/16/20)
 
Global Positive Perspectives Study, Wave 2: Understanding the Unmet Needs of People Living with HIV - (07/15/20)
 
The BICSTaR prospective cohort: Real-world effectiveness, safety and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in routine clinical practice in people living with HIV (PLWH) - (07/15/20)
 
Improved metabolic parameters after switching from TAF-based 3- or 4-drug regimen to the 2-drug regimen of DTG/3TC (dolutegravir/lamivudine): The TANGO study - (07/10/20)
 
108 reports.
AIDS 2020 - 23rd International AIDS Conference
July 6-8 2020
Virtual